Initiative to advance the application of J-Brain Cargo® blood-brain barrier penetration technology to the company’s own drugs, joint research with pharmaceutical companies, and technology out-licensing and licensing. The target applications are being expanded from lysosomal diseases to Alzheimer’s disease, while commercialization through external provision of the technology is also being pursued.